121 related articles for article (PubMed ID: 23689148)
1. Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: should we be concerned about it?
Ghaffari J; Ebrahimi M; Makhlough A; Mohammadjafari H; Nazari Z
Iran J Kidney Dis; 2013 May; 7(3):187-90. PubMed ID: 23689148
[TBL] [Abstract][Full Text] [Related]
2. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
Khameneh ZR; Baradaran M; Sepehrvand N
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311
[TBL] [Abstract][Full Text] [Related]
3. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
4. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis.
Azarpazhooh MR; Hasanpour K; Ghanbari M; Rezaee SA; Mashkani B; Hedayati-Moghaddam MR; Valizadeh N; Farid Hosseini R; Foroghipoor M; Soltanifar A; Sahebari M; Azadmanesh K; Hassanshahi G; Rafatpanah H
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1095-1101. PubMed ID: 22229796
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study.
Khameneh ZR; Sepehrvand N; Masudi S; Taghizade-Afshari A
Exp Clin Transplant; 2010 Jun; 8(2):146-9. PubMed ID: 20565372
[TBL] [Abstract][Full Text] [Related]
6. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
7. Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
Ahmadi Ghezeldasht S; Hedayati-Moghaddam MR; Habibi M; Mollahosseini F; Rafatpanah H; Miri R; Hatef Fard M; Sahebari M
Int J Rheum Dis; 2018 Jan; 21(1):108-113. PubMed ID: 28261958
[TBL] [Abstract][Full Text] [Related]
8. Serum human T-lymphotropic virus 1 proviral load in patients on hemodialysis.
Hekmat R; Gholami F; Ahmadnia H; Ahmadi M; Hassannia T
Iran J Kidney Dis; 2013 Mar; 7(2):124-8. PubMed ID: 23485536
[TBL] [Abstract][Full Text] [Related]
9. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad.
Safabakhsh H; Jalalian M; Karimi G
Glob J Health Sci; 2014 May; 6(5):99-104. PubMed ID: 25168999
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey.
Rafatpanah H; Hedayati-Moghaddam MR; Fathimoghadam F; Bidkhori HR; Shamsian SK; Ahmadi S; Sohgandi L; Azarpazhooh MR; Rezaee SA; Farid R; Bazarbachi A
J Clin Virol; 2011 Nov; 52(3):172-6. PubMed ID: 21840754
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of HTLV-1 virus infection in Togo (Kozah prefecture and the University Hospital Center of Lomé].
Balogou AA; Grunitzky EK; Anani TK; Kowu A; Sadzo-Hetsu A; Nubukpo KA; Dumas M
Bull Soc Pathol Exot; 2000 Feb; 93(1):3-5. PubMed ID: 10774482
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients.
Santos RF; Conceição GC; Martins MS; Kraychete A; Penalva MA; Carvalho EM; Lopes AA; Rocha PN
BMC Nephrol; 2017 Feb; 18(1):64. PubMed ID: 28202003
[TBL] [Abstract][Full Text] [Related]
16. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
Karimi G; Zadsar M; Pourfathollah AA
Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
[TBL] [Abstract][Full Text] [Related]
19. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study.
van der Ryst E; Joubert G; Smith MS; Terblanche M; Mollentze F; Pretorius AM
Cent Afr J Med; 1996 Mar; 42(3):65-8. PubMed ID: 8653770
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence of human T-cell lymphotropic virus type I in Curaçao and predictive variables for that infection].
Kamphuis DJ; Martina IS; Keli SO; Balentien EG; Top C
Ned Tijdschr Geneeskd; 1998 Jan; 142(2):89-92. PubMed ID: 9557000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
